Aveo Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Aveo Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $31,872 - $36,144	435 Added 8.63%	5,473 $443,000
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $39,631 - $43,239	536 Added 11.91%	5,038 $377,000
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $17,482 - $19,941	230 Added 5.38%	4,502 $346,000
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $66,331 - $75,572	858 Added 25.13%	4,272 $354,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $212,760 - $305,450	3,414 New	3,414 $293,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Aveo Capital Partners, LLC with notifications on news.